Cho Dennis sold $1.6M of TWST
Cho Dennis (See Remarks) sold 14,205 shares of Twist Bioscience Corp (TWST) at $109.75 ($1.56M total) on 2026-08-05 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete insider selling datapoint (shares, price, total value) but does not include new guidance, trial results, contracts, or regulatory actions.
Market read
Traders may briefly check for sentiment impact from insider selling, but the 10b5-1 framing suggests limited incremental information.
What to watch
The filing does not disclose reasons for the sale beyond the plan; without follow-on buys or company-specific news, the trading signal is weak.
Background
The article is an SEC Form 4 insider transaction report for Twist Bioscience, filed 2026-08-07, detailing an officer’s open-market sale under a 10b5-1 plan.
Ticker impact
Twist Bioscience insider Dennis Cho sold 14,205 shares at $109.75 on 2026-08-05 under a pre-arranged 10b5-1 plan.
Likely limited near-term impact; any reaction should be muted given the stated 10b5-1 plan.
Form 4 shows an open-market sale with a 10b5-1 plan, which typically reduces the signal-to-noise versus discretionary selling. The filing provides transaction size and price but no new company fundamentals.
Market effects
Minimal; insider sale disclosures rarely reset sector expectations without accompanying operational or regulatory news.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations, so traders may ignore it.
Key entities
- issuerTwist Bioscience Corp
Subject of the Form 4 insider transaction disclosure.
- insiderDennis Cho
Officer who sold 14,205 shares at $109.75 under a pre-arranged 10b5-1 plan.
